NCT04126876
- Conditions
- Malignant Melanoma, Melanoma, Neoplasms, +10 more
- Locations
-
- VU Medical Centere Amsterdam, Netherlands
Clinical trial condition
Malignant Melanoma
Explore clinical trials studying Malignant Melanoma. Study availability and eligibility vary by location and protocol.
169 public trials
21 recruiting studies
Malignant Melanoma trial results
Not yet recruiting
Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma
NCT06708455
- Conditions
- Malignant Melanoma, Malignant Melanoma Stage IIIc, Malignant Melanoma Stage IV, +13 more
- Locations
-
- Hackensack University Medical Center Hackensack, New Jersey, United States
Not yet recruiting
Immune PET and Proteomics for the Assessment of Response to Spatially Fractionated or Palliative Radiotherapy With or Without Immunotherapy
NCT06976021
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +37 more
- Locations
-
Not specified
Not yet recruiting
A Single-arm, Multicenter Clinical Study of Fruquintinib Combined With Cadonilimab Injection and Temozolomide in Second-line and Subsequent Treatment of Advanced Melanoma
NCT06553781
- Conditions
- Malignant Melanoma, Melanoma, Neoplasms, +10 more
- Locations
-
Not specified
Active, not recruiting
Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma
NCT05089370
- Conditions
- Malignant Melanoma, Melanoma, Neoplasms, +10 more
- Locations
-
- University of Colorado Hospital Aurora, Colorado, United States
Active, not recruiting
Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma
NCT00539591
- Conditions
- Malignant Melanoma, Melanoma, Neoplasms, +10 more
- Locations
-
- Rady Children's Hospital San Diego, California, United States
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
- The Children's Cancer Hospital at UT M.D. Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors
NCT02644369
- Conditions
- Adnexal Diseases, Advanced Solid Tumors, Breast Diseases, +33 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
Active, not recruiting
Binimetinib Encorafenib Pembrolizumab +/- Stereotactic Radiosurgery in BRAFV600 Melanoma With Brain Metastasis
NCT04074096
- Conditions
- BRAF V600 Mutation, Brain Diseases, Brain Metastases, +18 more
- Locations
-
- APHP - Hôpital Avicenne Bobigny, France
- CHU de Bordeaux - Hôpital Saint André Bordeaux, France
- GH Sud CHU Bordeaux - Hôpital Levêque Bordeaux, France
- APHP - Hôpital Ambroise Paré Boulogne-Billancourt, France
Active, not recruiting
SCIB1 and iSCIB1+ in Melanoma Patients Receiving Nivolumab With Ipilimumab or SCIB1 With Pembrolizumab (The SCOPE Study)
NCT04079166
- Conditions
- Malignant Melanoma, Melanoma, Melanoma (Skin), +13 more
- Locations
-
- Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom
- Velindre University NHS Trust Cardiff, United Kingdom
- The Leeds Teaching Hospitals NHS Trust Leeds, United Kingdom
- Guy's & St Thomas' NHS Foundation Trust London, United Kingdom
Active, not recruiting
Neoadjuvant L19IL2/L19TNF- Pivotal Study
NCT02938299
- Conditions
- Malignant Melanoma, Melanoma, Neoplasms, +10 more
- Locations
-
- Hôpital de la Timone Marseille, France
- Hôpital Universitaire de Nantes Nantes, France
- Institut Gustave Roussy Villejuif, France
- Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden Dresden, Germany